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Epicardial left ventricular leads via
minimally invasive technique: a role of
steroid eluting leads
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Christoph T. Starck2 and Tomas Holubec1,3*
Abstract
Background: We retrospectively assessed two types of sutureless screw-in left ventricular (LV) leads (steroid
eluting vs. non-steroid eluting) in cardiac resynchronization therapy (CRT) implantation with regards to their
electrical performance.
Methods: Between March 2008 and May 2014 an epicardial LV lead was implanted in 32 patients after failed
transvenous LV lead placement using a left-sided lateral minithoracotomy or video-assisted thoracoscopy (mean
age 64 ± 9 years). Patients were divided into two groups according to the type of implanted lead. Steroid eluting
(SE) group: 21 patients (Myodex™ 1084 T; St. Jude Medical) and non-steroid eluting (NSE) group: 11 patients
(MyoPore® 511,212; Greatbatch Medical).
Results: All epicardial leads could be placed successfully, without any intraoperative complications or mortality. With
regard to the implanted lead following results were observed: sensing (mV): SE 8.8 ± 6.1 vs. NSE 10.1 ± 5.3 (p = 0.380);
pacing threshold (V@0.5 ms): SE 1.0 ± 0.5 vs. NSE 0.9 ± 0.5 (p = 0.668); impedance (ohms): SE 687 ± 236 vs. NSE
790 ± 331 (p = 0.162). At the follow-up (2.6 ± 1.9 years) the following results were seen: sensing (mV): SE 8.7 ± 5.0 vs.
NSE 11.2 ± 6.6 (p = 0.241), pacing threshold (V@0.5 ms): SE 1.4 ± 0.5 vs. NSE 1.0 ± 0.3 (p = 0.035), impedance (ohms): SE
381 ± 95 vs. NSE 434 ± 88 (p = 0.129).
Conclusions: Based on the results no strong differences have been found between the both types of epicardial LV
leads (steroid eluting vs. non-steroid eluting) in CRT implantation in short- and midterm.
Keywords: Cardiac resynchronization therapy, Left ventricular lead, Steroid eluting lead, Non-steroid eluting lead,
Minimally invasive
Background
The prevalence and incidence of heart failure has
continuously increased in US and Europe during the
last decades [1]. Despite the advances in the optimal
medical treatment, strategies and therapies for
medically refractory symptomatic advanced heart fail-
ure have emerged, including cardiac resynchronization
therapy. Patients with New York Heart Association
(NYHA) class III or IV heart failure, who have left
ventricular ejection fraction (EF) of 35% or less, a sinus
rhythm with a QRS duration of ≥120 ms and a left
bundle branch block (LBBB) QRS morphology or a
QRS duration of ≥150 ms irrespective of QRS
morphology are according to the current guidelines
eligible to receive a cardiac resynchronization therapy
(CRT) [2, 3]. With a considerable number of CRT im-
plantations worldwide, the implantation success rate
has reached up to 90% with increasing experience of
implantation. The transvenous approach represents the
“gold standard” in implantation technique for CRT.
However, in case of failed transvenous coronary sinus
lead placement or lead extraction due to infection or
lead failure, epicardial left ventricular (LV) lead
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placement is required. Additionally, in patients under-
going cardiac interventions with open chest surgery
and present indication for CRT, the implantation of the
left ventricular lead can also be performed epicardially.
Despite few comparative studies on the different surgi-
cal LV leads, little is known about the short- and long-
term performance of the different sutureless epicardial
lead types.
The aim of the study was to investigate the differences
between two types of sutureless screw-in LV leads
(steroid eluting vs. non-steroid eluting) in CRT implant-
ation with regards to the electrical performance on the
short- and mid-term.
Methods
Study population and clinical data
We identified and retrospectively evaluated 32 consecu-
tive patients who underwent sutureless epicardial left
ventricular lead implantation either via left lateral mini-
thoracotomy, or video-assisted thoracoscopy at our insti-
tution between March 2008 and May 2014. Preoperative
variables and demographics are summarized in Table 1.
An intraoperative conversion or extension due to com-
plications was not necessary. Patients were divided into
two groups: steroid eluting LV lead (SE) group and non-
steroid eluting (NSE) LV lead group.
Perioperative and follow-up data was noted for opera-
tive time (minute), LV ejection fraction (%), clinical
NYHA class and the following electrical parameters:
sensing of underlying rhythm in millivolts (mV), pacing
lead impedance in ohms (Ω) and pacing thresholds
measured with a pulse width of 0.5 ms in volts (V @
0.5 ms).
Follow-up information was collected from our
database or medical records of referring cardiologists.
Data collection was performed prospectively. This
study was approved by local ethics committee (Ref.
KEK-ZH-Nr. 2014-0017) and the informed consent was
obtained from each patient.
Surgical technique
LV lead implantation of either steroid eluting (Myodex™
1084 T, St. Jude Medical, Inc., St. Paul, MN, USA) or
non-steroid eluting (MyoPore® 511,212, Greatbatch
Medical, Clarence, NY, USA) bipolar sutureless screw-in
leads were carried out through minithoracotomy or
video-assisted thoracoscopy.
Minithoracotomy
Epicardial left ventricular lead implantation via left lateral
minithoracotomy was performed in standard fashion as
previously described in general anesthesia and double-
lumen endotracheal intubation for selective lung ventila-
tion [4]. Briefly, anterolateral minithoracotomy was per-
formed in the fourth or fifth intercostal space. The
phrenic nerve was identified and the pericardium was
opened posteriorly, pericardial stay sutures were placed
for cardiac exposure, if necessary. After identification of
the optimal implantation site, sutureless leads were placed
on the designated location. Electrical parameters were
then measured and if necessary the leads repositioned.
Video-assisted thoracoscopy
Briefly, the procedure was carried out in general
anesthesia with the patient in supine position and select-
ive lung ventilation [4]. Three 10–12 mm ports were
inserted in the left hemithorax for endoscopic instru-
ments and scope. Under identification of the phrenic
nerve the pericardium was opened posteriorly and opti-
mal implantation site was selected. The screw-in leads
were then placed. Electrical parameters were then mea-
sured and if necessary the leads repositioned.
Statistical analysis
Continuous and discrete variables are presented as
mean ± standard deviation (SD) and medians and range
for data not normally distributed. They were compared
using a two-sample t-test or Mann-Whitney test, where
appropriate. Categorical and ordinal data are presented
as number and percentage of observations. They were
compared using Pearson’s Chi-squared test or Fischer’s
exact test, where appropriate. The probability of freedom
from event was calculated according to the Kaplan-
Meier method. Freedom-from-event curves were com-
pared by log-rank test. A p-value <0.05 was considered
to indicate statistical significance. Statistical analysis was
performed using IBM SPSS Statistics, Version 22 (IBM
Corp., Armonk, NY, USA).
Table 1 The preoperative data according to the type of left
ventricular lead
SE group
(n = 21)
NSE group
(n = 11)
p-value
Age, mean ± SD, years 67 ± 7 63 ± 11 0.158
Female gender 4 (19.1%) 4 (36.4%) 0.397
DCM 14 (66.7%) 7 (63.6%) 0.864
ICM 7 (33.3%) 4 (36.4%) 1.000
EF, mean ± SD, % 25 ± 7 24 ± 8 0.613
NYHA, mean ± SD 3 ± 1 3 ± 1 0.969
QRS duration, mean ± SD, ms 156 ± 25 155 ± 28 0.271
SE group – patients with steroid eluting left ventricular lead; NSE group –
patients with non-steroid eluting left ventricular lead. DCM – dilative
cardiomyopathy; EF – ejection fraction; ICM – ischemic cardiomyopathy; NYHA –
New York Heart Association functional class; QRS – electrocardiogram QRS
complex; SD – standard deviation
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Results
A total of 32 patients with mean age of 65 ± 9 years
(38–78 years) underwent a surgical implantation of
epicardial steroid and non-steroid eluting sutureless LV
leads. Dilated cardiomyopathy was present in 66% and
ischemic cardiomyopathy in 34% of patients with a mean
QRS length of 156 ± 25 ms. Median NYHA class was III
and mean EF was 25 ± 7%. Preoperative variables and
demographics are summarized in Table 1.
Twenty-one patients received steroid eluting leads (SE
group) and 11 patients non-steroid eluting leads (NSE
group). Twenty-eight patients underwent epicardial LV
lead implantation via left minithoracotomy and in 4 pa-
tients the video-assisted thoracoscopy was performed.
All but two patients have undergone previous failed
transvenous LV lead placement. All epicardial leads were
placed successfully, without any intraoperative complica-
tion. Median operative time was 90 (45–165) minutes in
the SE group and 105 (60–215) minutes in the NSE
group (p = 0.411) and mean length of hospital stay was
4 (1–16) days in the SE group and 6 (2–33) days in the
NSE group (p = 0.223), respectively. No statistical
significance was observed with regards to sensing,
pacing threshold, impedance, and length of hospital stay
between the groups. Operative data are shown in
Table 2.
The 30-days mortality was 0%. The mean follow-up was
2.6 ± 1.9 years (median 2.3 years, range 0.2–7.3 years).
Four late deaths (one in SE group and three in NSE group)
occurred during the follow-up (Fig. 1), two for cardiac rea-
sons and two of unknown cause. One patient had a lead
associated endocarditis in which the CRT system includ-
ing the epicardial LV lead was explanted. A subsequent
reimplantation of a new device was not undertaken due to
patient’s refusal. One CRT system was explanted
23 months after the implantation in a patient who was
listed for heart transplantation after receiving a donor
heart. During the follow-up, significant increase of LV-EF
and improved NYHA functional class was apparent with
no difference between both groups (Table 3). Sensing and
pacing threshold slightly increased throughout the whole
cohort, but without statistically significant difference
between the groups. However, values for impedance sig-
nificantly decreased, again without being different within
the SE and NSE groups (Table 3). The 4-year estimated
survival was 88 ± 8% and 70 ± 15% for SE and NSE group
(p = 0.226; Fig. 1), respectively.
Discussion
The “standard of care” of lead implantation for cardiac
resynchronization therapy remains still the less invasive
transvenous approach [5]. However, due to conditions
limiting the transvenous LV lead placement, a surgical
placement of an epicardial LV lead is then required.
Several issues may result in failed transvenous implant-
ation of the LV lead and/or requiring even primarily
surgical epicardial LV lead placement. As such, anatom-
ical limitations due to occlusion of the subclavian vein
or the superior vena cava and abnormal anatomy of the
coronary sinus are worth mentioning. Furthermore,
lead-related issues such as lead instability with repeated
dislodgement, phrenic nerve stimulation despite
electrical or physical optimization or systemic conditions
such as endocarditis as well as issues due to previous
transvenous lead implantation may contribute to failed
transvenous LV lead implantation [6].
Epicardial LV lead placement can be performed via left
anterolateral minithoracotomy, video-assisted thoraco-
scopy or with the support of a robotically enhanced tele-
manipulation system requiring general anesthesia with
its associated risks [4]. The surgical approach offers
excellent view on the targeted area and LV lead place-
ment takes place under direct visualization. Earlier
studies have shown similar outcomes of the surgical
approach with regards to endurance and performance of
epicardial LV leads [5, 7, 8]. Burger and colleagues
assessed aspects of different technical concepts (screw-in
vs. suture-on leads) of epicardial LV lead placement and
demonstrated an excellent long-term performance and
durability [9].
Short- and long-term effects of steroid eluting transve-
nous and epicardial pacing leads in pediatric and congenital
heart disease patients showed to be beneficial [10–12].
However, literature on the performance of steroid eluting
vs. non-steroid eluting epicardial LV leads is scarce, particu-
larly in the adult cardiac surgery population.
The present study enrolled 32 patients after implant-
ation of steroid eluting (n = 21) and non-steroid eluting
(n = 11) screw-in LV leads. Sensing and pacing thresh-
olds remained stable over the median follow-up time of
2.6 ± 1.9 years throughout the whole cohort, with low
median pacing thresholds of 1.3 V at 0.5 ms and no dif-
ference was observed between both groups. These
Table 2 The operative data according to the type of left
ventricular lead
SE group
(n = 21)
NSE group
(n = 11)
p-value
Operative time, mean ± SD, min 110 ± 49 116 ± 57 0.411
Length of hospital stay,
mean ± SD, days
6.4 ± 6.0 7.5 ± 7.3 0.223
30d-Mortality 0 0 1.000
Sensing, mean ± SD, mV 8.8 ± 6.1 8.4 ± 5.2 0.380
Pacing threshold, mean ± SD,
V@0.5 ms
1.0 ± 0.5 1.0 ± 0.7 0.668
Impedance, mean ± SD, ohms 687 ± 236 707 ± 302 0.162
SE group – patients with steroid eluting left ventricular lead; NSE group –
patients with non-steroid eluting left ventricular lead. SD – standard deviation
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findings are in line with previous reports [11, 13]. Never-
theless, in a study by Kutyifa et al. transvenous steroid
eluting leads showed a significantly lower pacing thresh-
old compared to non-steroid eluting transvenous leads
[14]. Horenstein and colleagues compared the perform-
ance of steroid eluting to non-steroid eluting epicardial
leads in a growing pediatric population over a period of
10 years. They concluded that steroid eluting epicardial
leads outperformed non-steroid eluting leads by their
stable and chronic low threshold over time and subse-
quent lower energy requirement [13]. The electrode-
tissue interface (area between cathode of the lead and
epimyocardium) is sought to be one of the critical fac-
tors for effective energy delivery to cardiac chambers. By
the incorporation of steroid elution by the early 1980’s
to this area, reliable and low stimulation threshold
pacing became possible by reducing the inflammatory
response at the site of implantation [15, 16]. Results of
the current study by means of stable pacing and sensing
thresholds, lead impedance and good lead survival seem
to be consistent with the findings of earlier reports.
The present study has several limitations. Although
prospective collection of data was performed, this was a
retrospective, non-randomized, observational study with
a heterogeneous patient population, and all inherent dis-
advantages apply. Next, the study is based on a single-
center experience. Finally, the number of patients in
groups was limited and the follow-up period was
relatively short.
Conclusions
All leads proved to be safe and effective in minimally
invasive epicardial left ventricular for cardiac resynchro-
nization therapy. Based on the results of the current
study no strong differences have been found between
the both types of bipolar sutureless screw-in left ven-
tricular leads (steroid eluting vs. non-steroid eluting) in
short- and mid-term period. Further studies with larger
Fig. 1 Kaplan-Meier curves showing survival in patients after sutureless left ventricular lead implantation (steroid eluting – solid line vs. non-
steroid eluting – dashed line) in cardiac resynchronization therapy
Table 3 The follow-up data according to the type of left
ventricular lead
SE group
(n = 21)
NSE group
(n = 11)
p-value
EF, mean ± SD, % 36.9 ± 11.8 38.1 ± 14.4 0.561
NYHA, mean ± SD 2.1 ± 0.6 2.1 ± 0.6 1.000
Responder rate 15 (71.4%) 8 (72.7%) 0.652
Mortality 1 (4.8%) 3 (27.2%) 0.226
Sensing, mean ± SD, mV 9.5 ± 5.7 9.6 ± 6.1 0.241
Pacing threshold, mean ± SD,
V@0.5 ms
1.3 ± 0.5 1.3 ± 0.6 0.074
Impedance, mean ± SD, ohms 396 ± 94 417 ± 106 0.056
SE group – patients with steroid eluting left ventricular lead; NSE group –
patients with non-steroid eluting left ventricular lead. EF – ejection fraction;
NYHA – New York Heart Association functional class; SD – standard deviation
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number of patients and possibly with randomized con-
trolled design and long-term follow up are needed to
further elucidate on this important issue.
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